Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required
Admin or Manager login required

Disease-Free Survival [přežití bez známek nemoci]

topical
1 454
Terms

přežití po terapii bez příznaků nemoci

 

Survival, Disease-Free

Persistent link   https://www.medvik.cz/link/D018572
Definition

Period after successful treatment in which there is no appearance of the symptoms or effects of the disease.

Annotation
usually NIM; coordinate with specific disease /ther or more specific qualifier
obvykle NIM; kombinuj s konkrétní nemocí s podheslem /terapie nebo přesnějšími kvalifikátory
DUI
D018572 MeSH Browser
CUI
M0027839
Previous indexing
Prognosis (1980-1994)
History note
95
Public note
95

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E01 Diagnosis 1 794
E01.789 Prognosis 9 806
E01.789.800 Treatment Outcome 22 068
E01.789.800.190 Disease-Free Survival 1 454
E01.789.800.238 Early Termination of Clinical Trials 17
E01.789.800.262 Pathologic Complete Response 8
E01.789.800.285 Progression-Free Survival 553
E01.789.800.379 Response Evaluation Criteria in Solid Tumors 44
E01.789.800.570 Sustained Virologic Response 20
E01.789.800.665 Therapeutic Index 6
E01.789.800.713 Treatment Expectations
E01.789.800.760 Treatment Failure 689
E05 Investigative Techniques 210
E05.318 Epidemiologic Methods 1 033
E05.318.740 Statistics as Topic 13 127
E05.318.740.998 Survival Analysis 3 098
E05.318.740.998.300 Disease-Free Survival 1 454
E05.318.740.998.650 Kaplan-Meier Estimate 741
E05.318.740.998.738 Progression-Free Survival 553
E05.318.740.998.825 Proportional Hazards Models 481

N Health Care
N04 Health Services Administration 1 758
N04.761 Quality of Health Care 2 515
N04.761.559 Outcome and Process Assessment, Health Care 1 870
N04.761.559.590 Outcome Assessment, Health Care 590
N04.761.559.590.800 Treatment Outcome 22 068
N04.761.559.590.800.190 Disease-Free Survival 1 454
N04.761.559.590.800.379 Early Termination of Clinical Trials 17
N04.761.559.590.800.427 Pathologic Complete Response 8
N04.761.559.590.800.474 Progression-Free Survival 553
N04.761.559.590.800.569 Response Evaluation Criteria in Solid Tumors 44
N04.761.559.590.800.665 Sustained Virologic Response 20
N04.761.559.590.800.713 Therapeutic Index 6
N04.761.559.590.800.737 Treatment Expectations
N04.761.559.590.800.760 Treatment Failure 689
N05 Health Care Quality, Access, and Evaluation 690
N05.715 Quality of Health Care 2 515
N05.715.360 Health Care Evaluation Mechanisms 202
N05.715.360.575 Outcome and Process Assessment, Health Care 1 870
N05.715.360.575.575 Outcome Assessment, Health Care 590
N05.715.360.575.575.800 Treatment Outcome 22 068
N05.715.360.575.575.800.190 Disease-Free Survival 1 454
N05.715.360.575.575.800.379 Early Termination of Clinical Trials 17
N05.715.360.575.575.800.427 Pathologic Complete Response 8
N05.715.360.575.575.800.474 Progression-Free Survival 553
N05.715.360.575.575.800.569 Response Evaluation Criteria in Solid Tumors 44
N05.715.360.575.575.800.665 Sustained Virologic Response 20
N05.715.360.575.575.800.713 Therapeutic Index 6
N05.715.360.575.575.800.737 Treatment Effect Heterogeneity 1
N05.715.360.575.575.800.749 Treatment Expectations
N05.715.360.575.575.800.760 Treatment Failure 689
N05.715.360.750 Statistics as Topic 13 127
N05.715.360.750.795 Survival Analysis 3 098
N05.715.360.750.795.300 Disease-Free Survival 1 454
N05.715.360.750.795.650 Kaplan-Meier Estimate 741
N05.715.360.750.795.738 Progression-Free Survival 553
N05.715.360.750.795.825 Proportional Hazards Models 481
N06 Environment and Public Health 203
N06.850 Public Health 4 060
N06.850.520 Epidemiologic Methods 1 033
N06.850.520.830 Statistics as Topic 13 127
N06.850.520.830.998 Survival Analysis 3 098
N06.850.520.830.998.300 Disease-Free Survival 1 454
N06.850.520.830.998.650 Kaplan-Meier Estimate 741
N06.850.520.830.998.825 Progression-Free Survival 553
N06.850.520.830.998.912 Proportional Hazards Models 481

Add